Brief: Cannabics Pharmaceuticals Initiates Entry For Its Cannabinoid Diagnostic Platform Into European Markets
14/07/2020 14:23
July 14 (Reuters) - Cannabics Pharmaceuticals Inc CNBX.PK :
* CANNABICS PHARMACEUTICALS INC - INITIATES PENETRATION FOR
ITS
CANNABINOID DIAGNOSTIC PLATFORM INTO EUROPEAN MARKETS
Source text for Eikon: ID:nPn5590hca
Further company coverage: CNBX.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CNBX Pharmaceuticals
See all newsBrief: Cannabics Pharmaceuticals Appoints Second Independent Board Member
Brief: Cannabics Prepares To Submit FDA With Pre-IND Meeting Request For Proprietary Colon Cancer Drug Candidate
Brief: Cannabics Pharmaceuticals Appoints Dr. Dana Ben-Ami Shor To Its Scientific Board Of Advisors
Brief: Cannabics Pharmaceuticals Initiates Entry For Its Cannabinoid Diagnostic Platform Into European Markets
Brief: Cannabics Pharmaceuticals & Cannomed Collaborate To Develop Cannabis Strains Targeting Cancers